BioXcel Therapeutics, Inc. (BTAI)
NASDAQ · Healthcare
BioXcel Therapeutics, Inc. Cash on Hand 2022–2025
BioXcel Therapeutics, Inc. annual/quarterly cash on hand history from 2022 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- BioXcel Therapeutics, Inc. cash on hand for the quarter ending December 31, 2025 were 28.4M, a 4.82% decrease year-over-year.
- BioXcel Therapeutics, Inc. cash on hand for 2025 were 28.4M, a 4.82% decrease from 2024.
- BioXcel Therapeutics, Inc. cash on hand for 2024 were 29.9M, a 54.23% decrease from 2023.
- BioXcel Therapeutics, Inc. cash on hand for 2023 were 65.2M, a 66.33% decrease from 2022.
- BioXcel Therapeutics, Inc. cash on hand for 2022 were 193.7M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| BioXcel Therapeutics, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $28 |
| 2024 | $30 |
| 2023 | $65 |
| 2022 | $194 |
| BioXcel Therapeutics, Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $28 |
| 2024-12-31 | $30 |
| 2023-12-31 | $65 |
| 2022-12-31 | $194 |
BioXcel Therapeutics, Inc. Cash on Hand — FAQ
BioXcel Therapeutics, Inc. (BTAI) cash on hand over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BTAI's cash on hand history?
The chart and table above show BioXcel Therapeutics, Inc.'s cash on hand by year and by quarter, including the growth rate.